6533b824fe1ef96bd1280234

RESEARCH PRODUCT

PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars: The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

A. FrenzelN. SchmidtJ. Grahl

subject

medicine.medical_specialtyEndocrinologyInternal medicineHealth PolicymedicinePublic Health Environmental and Occupational HealthBiosimilarBiologyGrowth hormoneGranulocyte colony-stimulating factorMarket penetration10.1016/j.jval.2012.08.581http://dx.doi.org/10.1016/j.jval.2012.08.581